1. Home
  2. JVA vs SCYX Comparison

JVA vs SCYX Comparison

Compare JVA & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVA
  • SCYX
  • Stock Information
  • Founded
  • JVA 1971
  • SCYX 1999
  • Country
  • JVA United States
  • SCYX United States
  • Employees
  • JVA N/A
  • SCYX N/A
  • Industry
  • JVA Packaged Foods
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JVA Consumer Staples
  • SCYX Health Care
  • Exchange
  • JVA Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • JVA 23.8M
  • SCYX 26.6M
  • IPO Year
  • JVA 2005
  • SCYX 2014
  • Fundamental
  • Price
  • JVA $4.21
  • SCYX $0.88
  • Analyst Decision
  • JVA
  • SCYX
  • Analyst Count
  • JVA 0
  • SCYX 0
  • Target Price
  • JVA N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • JVA 75.5K
  • SCYX 212.7K
  • Earning Date
  • JVA 09-12-2025
  • SCYX 08-19-2025
  • Dividend Yield
  • JVA N/A
  • SCYX N/A
  • EPS Growth
  • JVA 856.08
  • SCYX N/A
  • EPS
  • JVA 0.65
  • SCYX N/A
  • Revenue
  • JVA $84,651,329.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • JVA N/A
  • SCYX $410.22
  • Revenue Next Year
  • JVA N/A
  • SCYX $248.83
  • P/E Ratio
  • JVA $6.49
  • SCYX N/A
  • Revenue Growth
  • JVA 15.86
  • SCYX N/A
  • 52 Week Low
  • JVA $1.86
  • SCYX $0.66
  • 52 Week High
  • JVA $9.93
  • SCYX $1.82
  • Technical
  • Relative Strength Index (RSI)
  • JVA 46.60
  • SCYX 68.89
  • Support Level
  • JVA $4.31
  • SCYX $0.68
  • Resistance Level
  • JVA $4.33
  • SCYX $0.92
  • Average True Range (ATR)
  • JVA 0.22
  • SCYX 0.04
  • MACD
  • JVA -0.04
  • SCYX 0.02
  • Stochastic Oscillator
  • JVA 33.33
  • SCYX 83.33

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: